title: Are the proposed env mutations actually associated with resistance to maraviroc?
authors.forename: Annalisa
authors.initials: A
authors.lastname: Saracino
authors.forename: Laura
authors.initials: L
authors.lastname: Monno
authors.forename: Gaetano
authors.initials: G
authors.lastname: Brindicci
authors.forename: Giovanna
authors.initials: G
authors.lastname: Trillo
authors.forename: Maurantonio
authors.initials: M
authors.lastname: Altamura
authors.forename: Grazia
authors.initials: G
authors.lastname: Punzi
authors.forename: Antonella
authors.initials: A
authors.lastname: Lagioia
authors.forename: Gioacchino
authors.initials: G
authors.lastname: Angarano
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology*; D003510:Cyclohexanes / Q000494:pharmacology*; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000821:virology*; D015497:HIV-1 / Q000235:genetics* / Q000302:isolation & purification; D006801:Humans; D000077592:Maraviroc; D020125:Mutation, Missense; D014230:Triazoles / Q000494:pharmacology*; D054299:env Gene Products, Human Immunodeficiency Virus / Q000235:genetics*
chemical_list: D019380:Anti-HIV Agents; D003510:Cyclohexanes; D014230:Triazoles; D054299:env Gene Products, Human Immunodeficiency Virus; D000077592:Maraviroc